TASS/. The Health Insurance Administration of South China's Hainan Province has temporarily included the country's oral anti-Covid drug Azvudine into the list of medicine covered by medical insurance.

Tong, An, and their colleagues have also helped conduct tests on an antiviral oral drug called Azvudine 5 for its efficacy against SARS CoV-2. Azvudine inhibits the replication of viral RNA and ...

China will include two other COVID-19 drugs, the Chinese-made antiviral Azvudine and the Chinese herbal blend medicine Qingfei Paidu Granules, the National Healthcare Security Administration said ...